Harrow to Present at Two Investor Conferences in May May 14, 2025 07:00AM
Harrow to Present at Two Investor Conferences in May May 15, 2024 07:00AM
Harrow Health (HROW) Prices 3.38M Share Offering at $17.75/sh Jul 19, 2023 07:00AM
Harrow Prices $60 Million Public Offering of Common Stock Jul 19, 2023 07:00AM
Harrow Health (HROW) Announces Proposed Share Offering Jul 18, 2023 04:04PM


Jul 18, 2023 04:04PM Harrow Announces Proposed Public Offering of Common Stock
May 17, 2023 08:00AM Harrow to Participate in B. Riley Securities 23rd Annual Institutional Investor Conference on May 24, 2023
Mar 28, 2023 02:59PM B. Riley Leads Financing to Support Harrow Health Acquisition
Mar 28, 2023 07:07AM Harrow Health (HROW) Enters $100M Secured Credit Facility with Oaktree
Mar 28, 2023 07:00AM Harrow Announces New $100 Million Secured Credit Facility with Oaktree
Jan 4, 2023 05:55PM Today’s most important price target changes
Dec 16, 2022 07:00AM Harrow Secures Capital to Close Recently Announced Acquisition
Dec 14, 2022 06:34AM Harrow Health (HROW) to offer $100 million of senior notes due in 2027
Dec 14, 2022 06:34AM Harrow Health (HROW) prices 2.38 million shares at $10.52
Dec 14, 2022 06:32AM Harrow Announces Proposed Offering of $100 Million of Senior Notes Due 2027 and “BB” Rating from Egan-Jones
Dec 14, 2022 06:31AM Harrow Prices $25 Million Offering
Apr 22, 2022 08:00AM Harrow Health to Participate in B. Riley Securities’ Annual Neuro & Ophthalmology Investor Conference
Dec 20, 2021 07:03AM Harrow Health (HROW) Acquires U.S. Commercial Rights to Four Branded Eye Drops
Dec 20, 2021 07:00AM Harrow Health Acquires U.S. Commercial Rights to Four Branded Eye Drops
Aug 18, 2021 07:06AM Harrow Health (HROW) Acquires Ophthalmic Surgical Drug Candidate From Wakamoto Pharmaceutical Co., Ltd.
Aug 18, 2021 07:00AM Harrow Health Acquires Ophthalmic Surgical Drug Candidate From Wakamoto Pharmaceutical Co., Ltd.
Jul 27, 2021 07:00AM Harrow Health Acquires Patented Ophthalmic Surgical Drug Candidate from Sintetica
Jun 17, 2021 04:01PM Harrow Health Announces Closing of $20 Million Aggregate Principal Amount Offering of 8.625% Senior Notes Due 2026
Jun 14, 2021 05:59PM Harrow Health Announces Pricing of $17.5 Million Aggregate Principal Amount Offering of 8.625% Senior Notes Due 2026
Jun 14, 2021 07:45AM Harrow Health Announces Offering of $17.5 Million of 8.625% Senior Notes Due 2026 and “BB” Rating from Egan-Jones
May 5, 2021 04:03PM Harrow Health Raises Approximately $11 Million in Sale of Series B Preferred Stock
May 5, 2021 04:01PM Harrow Health Announces Full Exercise and Closing of Option to Purchase Additional Senior Notes
Apr 20, 2021 04:01PM Harrow Health Announces Closing of $50 Million Offering of Senior Notes Due 2026
Apr 15, 2021 05:00PM Harrow Health Announces Pricing of $50 Million Offering of Senior Notes Due 2026
Apr 14, 2021 04:01PM Harrow Health Announces Offering of $25 Million Senior Notes Due 2026 and “BB” Rating from Egan-Jones
Sep 2, 2020 06:46AM Companies with NDRs 09/02
Sep 1, 2020 07:09AM Companies with NDRs 09/01
Aug 31, 2020 07:13AM Companies with NDRs 08/31
Aug 29, 2019 06:40AM Companies with NDRs 08/29
May 7, 2019 07:00AM Harrow Health to Present at the 20th Annual B. Riley FBR Institutional Investor Conference on May 22, 2019